Our previous findings demonstrated that the overexpression of IFNβ in a tumor microenvironment leads to the enhanced expression of Gzmb (granzyme B) and MHC I (major histocompatibility complex I), resulting in effective tumor suppression in vivo [39]. The gene discussed is GZMB; the disease is neoplasm.